259 related articles for article (PubMed ID: 31219806)
1. Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
Ebrahimi-Nik H; Michaux J; Corwin WL; Keller GL; Shcheglova T; Pak H; Coukos G; Baker BM; Mandoiu II; Bassani-Sternberg M; Srivastava PK
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31219806
[TBL] [Abstract][Full Text] [Related]
2. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
3. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
4. Immunization with short peptide particles reveals a functional CD8
He X; Zhou S; Dolan M; Shi Y; Wang J; Quinn B; Jahagirdar D; Huang WC; Tsuji M; Pili R; Ito F; Ortega J; Abrams SI; Ebos JML; Lovell JF
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34862254
[TBL] [Abstract][Full Text] [Related]
5. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy.
Wilson EA; Anderson KS
Expert Rev Proteomics; 2018 Dec; 15(12):1065-1077. PubMed ID: 30408427
[TBL] [Abstract][Full Text] [Related]
6. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
[TBL] [Abstract][Full Text] [Related]
7. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity.
Duan F; Duitama J; Al Seesi S; Ayres CM; Corcelli SA; Pawashe AP; Blanchard T; McMahon D; Sidney J; Sette A; Baker BM; Mandoiu II; Srivastava PK
J Exp Med; 2014 Oct; 211(11):2231-48. PubMed ID: 25245761
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro.
Gillig MA; Brennick CA; George MM; Balsbaugh JL; Shcheglova TV; Mandoiu II; Rosales T; Baker BM; Srivastava PK; Karandikar SH
J Immunol; 2023 Dec; 211(12):1783-1791. PubMed ID: 37966257
[TBL] [Abstract][Full Text] [Related]
9. An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.
Brennick CA; George MM; Moussa MM; Hagymasi AT; Seesi SA; Shcheglova TV; Englander RP; Keller GL; Balsbaugh JL; Baker BM; Schietinger A; Mandoiu II; Srivastava PK
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33320837
[TBL] [Abstract][Full Text] [Related]
10. Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Wickström SL; Lövgren T; Volkmar M; Reinhold B; Duke-Cohan JS; Hartmann L; Rebmann J; Mueller A; Melief J; Maas R; Ligtenberg M; Hansson J; Offringa R; Seliger B; Poschke I; Reinherz EL; Kiessling R
Front Immunol; 2019; 10():2766. PubMed ID: 31921104
[TBL] [Abstract][Full Text] [Related]
11. The neoepitope landscape of breast cancer: implications for immunotherapy.
Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cancer neoepitopes needs new rules.
Brennick CA; George MM; Srivastava PK; Karandikar SH
Semin Immunol; 2020 Feb; 47():101387. PubMed ID: 31952902
[TBL] [Abstract][Full Text] [Related]
13. Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development.
Zaidi N; Soban M; Chen F; Kinkead H; Mathew J; Yarchoan M; Armstrong TD; Haider S; Jaffee EM
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32879142
[TBL] [Abstract][Full Text] [Related]
14. Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy.
Lee KL; Benz SC; Hicks KC; Nguyen A; Gameiro SR; Palena C; Sanborn JZ; Su Z; Ordentlich P; Rohlin L; Lee JH; Rabizadeh S; Soon-Shiong P; Niazi K; Schlom J; Hamilton DH
Cancer Immunol Res; 2019 Aug; 7(8):1359-1370. PubMed ID: 31292145
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.
Reimann H; Nguyen A; Sanborn JZ; Vaske CJ; Benz SC; Niazi K; Rabizadeh S; Spilman P; Mackensen A; Ruebner M; Hein A; Beckmann MW; van der Meijden ED; Bausenwein J; Kretschmann S; Griffioen M; Schlom J; Gulley JL; Lee KL; Hamilton DH; Soon-Shiong P; Fasching PA; Kremer AN
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172517
[TBL] [Abstract][Full Text] [Related]
16. New epitopes in ovalbumin provide insights for cancer neoepitopes.
Karandikar SH; Sidney J; Sette A; Selby MJ; Korman AJ; Srivastava PK
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869653
[TBL] [Abstract][Full Text] [Related]
17. T Cell Epitope Prediction and Its Application to Immunotherapy.
Schaap-Johansen AL; Vujović M; Borch A; Hadrup SR; Marcatili P
Front Immunol; 2021; 12():712488. PubMed ID: 34603286
[TBL] [Abstract][Full Text] [Related]
18. Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.
Brennick CA; George MM; Corwin WL; Srivastava PK; Ebrahimi-Nik H
Immunotherapy; 2017 Mar; 9(4):361-371. PubMed ID: 28303769
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
20. Induction of neoantigen-reactive T cells from healthy donors.
Ali M; Foldvari Z; Giannakopoulou E; Böschen ML; Strønen E; Yang W; Toebes M; Schubert B; Kohlbacher O; Schumacher TN; Olweus J
Nat Protoc; 2019 Jun; 14(6):1926-1943. PubMed ID: 31101906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
